13F filer · CIK 1232621
TANG CAPITAL MANAGEMENT LLC
SAN DIEGO, CA · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$2.2B
+$232.8M vs prior
Positions
41
New / sold out
5 / 15
Added / reduced
7 / 5
Turnover
9.2%
buys $190.8M · sells $202.7M
Top-10 weight
62.7%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | NUVECTIS PHARMA INC | +1,550,000 | – | +$28.5M |
| Added | CELCUITY INC | +264,594 | +25.2% | +$27.7M |
| Added | TARSUS PHARMACEUTICALS INC | +379,642 | +31.9% | +$23.9M |
| New | FULCRUM THERAPEUTICS INC | +6,521,412 | – | +$23.9M |
| New | NANO DIMENSION LTD | +14,292,813 | – | +$20.7M |
| Added | CAPRICOR THERAPEUTICS INC | +700,000 | +20.6% | +$16.9M |
| Added | COMPASS PATHWAYS PLC | +997,800 | +24.9% | +$14.1M |
| Added | AURINIA PHARMACEUTICALS INC | +814,606 | +6.7% | +$13.8M |
| New | GOSSAMER BIO INC | +17,841,000 | – | +$11.5M |
| New | BOUNDLESS BIO INC | +2,559,875 | – | +$6.4M |
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | KALVISTA PHARMACEUTICALS INC | -4,573,530 | -100.0% | $-92.1M |
| Reduced | SPYSTATE STR SPDR S&P 500 ETF T | -45,000 | -26.8% | $-33.6M |
| Reduced | INSMED INC | -160,000 | -61.5% | $-17.1M |
| Sold out | JANUX THERAPEUTICS INC | -500,000 | -100.0% | $-7.0M |
| Reduced | STOKE THERAPEUTICS INC | -200,000 | -40.0% | $-6.5M |
| Sold out | BIOGEN INC | -35,000 | -100.0% | $-6.4M |
| Sold out | UROGEN PHARMA LTD | -350,000 | -100.0% | $-6.3M |
| Sold out | ARVINAS INC | -538,658 | -100.0% | $-5.7M |
| Sold out | KEZAR LIFE SCIENCES INC | -664,314 | -100.0% | $-4.9M |
| Reduced | MODERNA INC | -50,000 | -50.0% | $-3.5M |
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | AURINIA PHARMACEUTICALS INCCOM | 13,044,106 | $221.4M | 10.05% |
| 2 | SPYRE THERAPEUTICS INCCOM NEW | 1,892,200 | $168.0M | 7.63% |
| 3 | MIRUM PHARMACEUTICALS INCCOM | 1,236,027 | $144.7M | 6.57% |
| 4 | KINIKSA PHARMACEUTICALS INTLORD SHS CL A | 2,259,889 | $144.5M | 6.56% |
| 5 | CELCUITY INCCOM | 1,314,594 | $137.5M | 6.25% |
| 6 | CORCEPT THERAPEUTICS INCCOM | 1,500,000 | $130.4M | 5.92% |
| 7 | PTC THERAPEUTICS INCCOM | 1,500,000 | $122.4M | 5.56% |
| 8 | LAKEFRONT BIOTHERAPEUTICS NVSPON ADR | 3,785,991 | $113.5M | 5.16% |
| 9 | CAPRICOR THERAPEUTICS INCCOM NEW | 4,099,900 | $98.7M | 4.48% |
| 10 | TARSUS PHARMACEUTICALS INCCOM | 1,568,266 | $98.7M | 4.48% |
31 more rows. Subscribe for $29/month to see every row, download the data and use the API.